Abstract
Midazolam (MDL) was known to act through stimulation of benzodiazepine receptors (GABA). Whether midazolam affects ion currents and membrane potential in neurons remains largely unclear. Electrophysiological studies of midazolam actions were performed in differentiated motor neuron-like (NSC-34 and NG108-15) cells. Midazolam suppressed the amplitude of delayed rectifier K+ current (IK(DR)) in a time- and concentration-dependent manner with an IC50 value of 10.4 μM. Addition of midazolam was noted to enhance the rate of IK(DR) inactivation. On the basis of minimal binding scheme, midazolam-induced block of IK(DR) was quantitatively provided with a dissociation constant of 9.8 μM. Recovery of I K(DR) from inactivation in the presence of midazolam was fitted by a single exponential. midazolam had no effect on M-type or erg-mediated K + current in these cells. Midazaolam (30 μM) suppressed the peak amplitude of voltage-gated Na+ current (INa) with no change in the current-voltage relationships of this current. Inactivation kinetics of INa remained unaltered in the presence of this agent. In current-clamp configuration, midazolam (30 μM) prolonged the duration of action potentials (APs) and reduce AP amplitude. Similarly, in differentiated NG108-15 cells, the exposure to midazolam also suppressed IK(DR) with a concomitant increase in current inactivation. Midazolam can act as an open-channel blocker of delayed-rectifier K+ channels in these cells. The synergistic blocking effects on IK(DR) and INa may contribute to the underlying mechanisms through which midazolam affects neuronal function in vivo.
| Original language | English |
|---|---|
| Pages (from-to) | 152-160 |
| Number of pages | 9 |
| Journal | European Journal of Pharmacology |
| Volume | 724 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2014 Feb 5 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology
Cite this
}
Effects of midazolam on ion currents and membrane potential in differentiated motor neuron-like NSC-34 and NG108-15 cells. / So, Edmund Cheung; Wu, King Chuen; Kao, Feng Chen; Wu, Sheng-Nan.
In: European Journal of Pharmacology, Vol. 724, No. 1, 05.02.2014, p. 152-160.Research output: Contribution to journal › Article
TY - JOUR
T1 - Effects of midazolam on ion currents and membrane potential in differentiated motor neuron-like NSC-34 and NG108-15 cells
AU - So, Edmund Cheung
AU - Wu, King Chuen
AU - Kao, Feng Chen
AU - Wu, Sheng-Nan
PY - 2014/2/5
Y1 - 2014/2/5
N2 - Midazolam (MDL) was known to act through stimulation of benzodiazepine receptors (GABA). Whether midazolam affects ion currents and membrane potential in neurons remains largely unclear. Electrophysiological studies of midazolam actions were performed in differentiated motor neuron-like (NSC-34 and NG108-15) cells. Midazolam suppressed the amplitude of delayed rectifier K+ current (IK(DR)) in a time- and concentration-dependent manner with an IC50 value of 10.4 μM. Addition of midazolam was noted to enhance the rate of IK(DR) inactivation. On the basis of minimal binding scheme, midazolam-induced block of IK(DR) was quantitatively provided with a dissociation constant of 9.8 μM. Recovery of I K(DR) from inactivation in the presence of midazolam was fitted by a single exponential. midazolam had no effect on M-type or erg-mediated K + current in these cells. Midazaolam (30 μM) suppressed the peak amplitude of voltage-gated Na+ current (INa) with no change in the current-voltage relationships of this current. Inactivation kinetics of INa remained unaltered in the presence of this agent. In current-clamp configuration, midazolam (30 μM) prolonged the duration of action potentials (APs) and reduce AP amplitude. Similarly, in differentiated NG108-15 cells, the exposure to midazolam also suppressed IK(DR) with a concomitant increase in current inactivation. Midazolam can act as an open-channel blocker of delayed-rectifier K+ channels in these cells. The synergistic blocking effects on IK(DR) and INa may contribute to the underlying mechanisms through which midazolam affects neuronal function in vivo.
AB - Midazolam (MDL) was known to act through stimulation of benzodiazepine receptors (GABA). Whether midazolam affects ion currents and membrane potential in neurons remains largely unclear. Electrophysiological studies of midazolam actions were performed in differentiated motor neuron-like (NSC-34 and NG108-15) cells. Midazolam suppressed the amplitude of delayed rectifier K+ current (IK(DR)) in a time- and concentration-dependent manner with an IC50 value of 10.4 μM. Addition of midazolam was noted to enhance the rate of IK(DR) inactivation. On the basis of minimal binding scheme, midazolam-induced block of IK(DR) was quantitatively provided with a dissociation constant of 9.8 μM. Recovery of I K(DR) from inactivation in the presence of midazolam was fitted by a single exponential. midazolam had no effect on M-type or erg-mediated K + current in these cells. Midazaolam (30 μM) suppressed the peak amplitude of voltage-gated Na+ current (INa) with no change in the current-voltage relationships of this current. Inactivation kinetics of INa remained unaltered in the presence of this agent. In current-clamp configuration, midazolam (30 μM) prolonged the duration of action potentials (APs) and reduce AP amplitude. Similarly, in differentiated NG108-15 cells, the exposure to midazolam also suppressed IK(DR) with a concomitant increase in current inactivation. Midazolam can act as an open-channel blocker of delayed-rectifier K+ channels in these cells. The synergistic blocking effects on IK(DR) and INa may contribute to the underlying mechanisms through which midazolam affects neuronal function in vivo.
UR - http://www.scopus.com/inward/record.url?scp=84892410873&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892410873&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2013.12.034
DO - 10.1016/j.ejphar.2013.12.034
M3 - Article
C2 - 24374009
AN - SCOPUS:84892410873
VL - 724
SP - 152
EP - 160
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
SN - 0014-2999
IS - 1
ER -